Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...

In combination with established tumor markers, EDTA-plasma Tumor M2-PK ... PK testing is a good noninvasive screening parameter for colorectal cancer with a reported sensitivity of 68.8-91.0% ...

The aim is to identify colorectal cancer subtypes so that these can then be treated in a customized manner. Two informative markers are microsatellite instability (MSI) and tumor-infiltrating ...

Since Henry Bence Jones first discovered a urine protein marker for multiple myeloma in 1846, the field of cancer biomarkers has grown exponentially. Over the past two centuries, scientists have ...

CytoDyn has received FDA clearance to initiate a Phase II study of leronlimab in patients with relapsed or refractory micro-satellite stable colorectal ... targets CCR5 marker on the tumor.

Proliferating cells, in particular tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed Tumor M2 pyruvate kinase. In the last few years, much attention has been paid to this novel ...